Big Pharma market pressures limit Biotech innovation
The U.S. biotech industry is under strain due to being forced into structures designed for pharma companies. This leads to issues such as political risks and a lack of suitable funding.
Yearly Archives
2026
Trump Expands Prescription Drug Website TrumpRx to Include More Medications
Trump announces sevenfold expansion of his prescription drug website, TrumpRx, amid criticism over limited drug…
Nancy Pelosi Endorses Connie Chan for Congress in San Francisco Race
Pelosi endorses Connie Chan for Congress, potentially pushing her into second place behind leading candidate Sen.…
Rapid Increase in Privacy Fines Calls for Urgent Business Adaptation
Stay updated with business and technology trends as our experienced Kiplinger Letter team provides latest developments and forecasts.
Supreme Court Approves Discount Pricing
Supreme Court rejects pharma companies' appeal against Medicare’s drug price negotiation program, reinforcing…
Native American and Hawaiian Legal Groups Defend Scholarship Program in Court
On May 15, 2026, Native American Rights Fund, NHLC, and Hobbs, Straus, Dean & Walker, LLP filed a Motion to…
‘SNL Mocks Kari Lake Once More: The Unfortunate Punchline’
Explore the influence of "Saturday Night Live" on music, in a new exhibit at the Rock and Roll Hall of Fame, Cleveland.
Troubleshooting Steps: Resolve Site Loading Issues due to Browser Extensions
Explore website content coded for optimal viewing and functionality, including font, styles, and JavaScript…
Agentic AI in Healthcare: A Look at SoundHound AI, Evolent Health, and C3.ai
SoundHound AI, Evolent Health and C3.ai are capturing opportunities in low-cost automation platforms in healthcare…
US needs $1.5T to match China’s 2026 industrial level, says ITIF report
"Hamilton Index 2026 reports China's share in global production of advanced industries rose from 3.5% to almost 25%, leading 7 of 10 strategic sectors."